Early Neurophysiological Interventions in Acute Cerebral Lesions

Objective:

Transcranial direct current stimulation (tDCS) can change the excitability of the central nervous system and contribute to motor recovery of stroke patients. The investigators hypothesized that the benefit of tDCS may increase with interventions facilitating motor responses, such as repetitive peripheral nerve stimulation (rPNS).

The aim of our study was to examine the short and long-term effects of real vs sham bihemispheric tDCS on scales of motor function and neurophysiological tests in patients with acute stroke and a moderate/severe motor impairment.

Methods:

The study was prospective, randomized, double-blind and placebo controlled. Twenty acute stroke patients (ischemic and haemorrhagic) with Upper limb Fugl-Meyer (ULFM) score\<19 were randomized in two parallel groups: one group received 5 consecutive daily sessions of anodal tDCS over the affected hemisphere (AH) and cathodal over unaffected hemisphere combined with rPNS and the other received sham tDCS associated to rPNS. Pacients were examined before tDCS, 5 days and 3, 6 and 12 months after tDCS. The investigators evaluated ULFM and modified Ashworth scales (MAS), resting motor threshold, motor and somatosensory evoked potentials (MEPs and SEPs), silent periods and Hmax/Mmax ratio.

Transcranial direct current stimulation (tDCS) is a form of noninvasive brain stimulation used to induce excitability changes in central nervous system circuits. The basis of tDCS application in stroke patients follows the model of interhemispheric imbalance between the damaged and intact hemispheres: anodal tDCS over affected hemisphere to induce long-lasting increase in cortical excitability, cathodal tDCS over unaffected hemisphere to induce long-lasting decrease in cortical excitability. Simultaneous effects on both hemispheres can be obtained with bi-hemispheric tDCS. Minimum intensity and duration of tDCS is necessary to induce long-lasting effects, which are referred as long-term potentiation and long-term depression.

Most interventional tDCS studies have focused on chronic stroke patients, at a time in which patients are supposed to have reached a plateau in their spontaneous recovery after the lesion. Less research has evaluated the effects of an early tDCS intervention. tDCS protocols differ in location of electrodes, session frequency and duration, dosage of electrical charge, temporal window of tDCS delivery and other variables. The functional benefit of tDCS may increase with the concomitant application of adjuvant therapeutic strategies such as constraint-induced therapy, electrical stimulation or robot-mediated therapy. Sattler et al. used radial nerve stimulation, together with tDCS, to facilitate motor output. It is possible that repetitive peripheral nerve stimulation (rPNS) modulates corticospinal output at somatotopically specific supraspinal sites through GABAergic interneurons. The patients that improved in Sattler et al.'s study, as in other tDCS studies, had an initial mild to moderate impairment of motor function. Improvement is more dubious in patients presenting with severe motor deficit.

Our aim in this study was to examine the effectiveness of bihemispheric tDCS combined with rPNS in acute stroke patients with pronounced motor impairment, the group of patients with fewer options in therapeutic programs.

The benefit of applying tDCS early after stroke is still unclear. However, based on animal models, the first month after stroke seems to be the optimal period to induce morphological changes associated with increased plasticity, hence the therapeutic window was chosen between 5 and 20 days after the stroke event. The investigators reasoned that, if plastic changes have been induced by tDCS, the clinical and neurophysiological benefit may manifest not just immediately after treatment, but further ahead in the patient's natural evolution after the stroke. For this reason, the investigators considered relevant to determine if the results of tDCS treatment persisted in time and had a long-term effect, therefore extended our clinical and neurophysiological follow-up to 12 months after treatment.

Methods:

Patients:

Twenty patients with a history of first acute stroke (ischemic and haemorrhagic) were included, from April through December 2011, in a prospective, double-blind, randomized study. Eleven patients were affected by an ischemic stroke: cortical and/or subcortical and 9 were affected by a haemorrhagic stroke. Inclusion criteria were: first time single and unilateral supratentorial stroke confirmed by CT or MRI, stroke interval between 5 and 20 days of study onset, age 18 to 79 years, National Institutes of Health Stroke Scale (NIHSS) ≥6 and ≤21. Exclusion criteria were preceding epileptic seizures, metallic implants within the brain or pacemaker implants and coexistence of other neurological diseases.

Patients were included in the study when they were medically stable, between 5 and 17 days after the stroke event. The study was conducted in according to the World Medical Association Declaration of Helsinki and approved by the Clinical Research Ethics Committee (PR160/11). Written, informed consent was obtained from all participants or their relatives before their inclusion in the study.

Patients were randomized in two parallel groups: one group (11 patients) received 5 consecutive daily sessions of anodal tDCS over the affected hemisphere and cathodal over unaffected hemisphere combined with repetitive peripheral nerve stimulation and the other (9 patients) received sham tDCS associated to repetitive peripheral nerve stimulation.

Patients were examined before tDCS, 5 days and 3, 6 and 12 months after tDCS.

Assessments Patients' condition was characterized using standardized clinical and neurophysiological assessment tools on the day before onset of interventions.

Clinical assessment Neurological functioning was assessed using the NIHSS. Motor assessment of the paretic upper limb and spasticity were evaluated using the upper limb Fugl-Meyer (ULFM) and Modified Ashworth scales (MAS). MAS scale measures were taken for shoulder abduction, elbow extension and wrist extension, which were used to calculate the mean value of resistance during passive stretching, with higher scores reflecting greater resistance (maximum 4).

Neurophysiological assessment

Transcranial magnetic stimulation:

Motor evoked potentials (MEPs) were recorded using a biphasic magnetic stimulator (Magstim 200; The Magstim Co. Ltd., UK) connected to a figure-of-eight magnetic stimulating coil (70-mm outer diameter; The Magstim Co. Ltd., UK) placed over the cortical abductor digiti minimi hotspot. A tight-fitting cloth cap marked with a 1cmx1cm grid was used for the mapping of the target muscle cortical representation. The coil was positioned tangentially to the scalp, with the handle pointing backwards at an angle of 45 degrees to midline and was moved in 1-cm steps to localize the optimal scalp location in each hemisphere, from which the largest MEPs in the abductor digiti minimi could be evoked. A Synergy electromyograph (Oxford Instruments, Surrey, UK) was used to record MEPs from the abductor digiti minimi. Whenever MEPs were not elicited in the affected upper limb at rest using maximal stimulator output, patients were instructed to make an attempt to voluntarily activate the muscle. If no MEP could be elicited using maximal stimulator output, MEPs amplitude was described as 0 mV.

Groppa S, Oliviero A, Eisen A et al. A practical guide to diagnostic transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol 2012;123:858-882.

Resting motor threshold:

Resting motor threshold (rMT) was defined as the lowest stimulator output at the optimal scalp site required to elicit a MEP of at least 50 μV in the relaxed abductor digiti minimi in at least 5 of 10 trials.21 If no MEP could be elicited using maximal stimulator output, then rMT was described as 100%.

Contralateral and ipsilateral silent period:

To elicit the silent period, transcranial magnetic stimulation was applied over the M1 area of each hemisphere while patients sustained a steady maximum tonic contraction of the abductor digiti minimi and a 500ms poststimulus period was analysed. Stimulation intensity was 120% rMT. We essentially recorded simultaneously contralateral (cSP) and ipsilateral silent period (iSP) to a unilateral stimulus. If patients were unable to maintain a stable contraction with the paretic hand, the SP was considered unmeasurable. cSP duration was measured from the onset of the MEP to the point of EMG resumption after a period of EMG suppression and the mean of 10 trials was used to estimate the silent period duration. iSP was quantified considering a period of relative suppression of EMG activity below the background EMG activity.

Takechi U, Matsunaga K, Nakanishi R et al. Longitudinal changes of motor cortical excitability and transcallosal inhibition after subcortical stroke. Clin Neurophysiol 2014;125: 2055-2069.

SEPs recording:

Somatosensory evoked potentials (SEPs) were elicited using electrical stimulation with the same procedure described in detail in previous studies. Signals were recorded using Synergy electromyograph (Oxford Instruments, Surrey, UK). SEPs data were compared between affected and unaffected upper limbs.

Cruccu G, Aminoff MJ, Curio G et al. Recommendations for the clinical use of somatosensory-evoked potentials. Clin Neurophysiol 2008;119:1705-19.

Mauguière F, Allison T, Babiloni C et al. Somatosensory evoked potentials. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl 1999;52:79-90.

H-reflex H-reflex responses were recorded from a 45-degree angle supinated arm and a slightly contracted flexor carpi radialis muscle. When the flexor carpi radialis muscle couldn't be contracted the paretic upper limb was positioned with the wrist in slight flexion. Recording electrode was placed over the belly of the flexor carpi radialis and referred to an electrode 3 cm distal. Electrical stimuli delivered a square-wave pulse of 0.5 ms in duration and were applied over the median nerve at the bicipital groove; above the cubital crease. Hmax/Mmax responses were compared between the paretic and non-paretic sides.

Christie AD, Inglis JG, Boucher JP, Gabriel DA. Reliability of the FCR H-reflex. J Clin Neurophysiol 2005;22:204-9.

Eligibility Criteria:
Inclusion Criteria:

* first time single and unilateral supratentorial stroke confirmed by CT or MRI.
* stroke interval between 5 and 20 days of study onset.
* age 18 to 79 years,
* National Institutes of Health Stroke Scale (NIHSS) ≥6 and ≤21.

Exclusion Criteria:

* preceding epileptic seizures.
* metallic implants within the brain or pacemaker implants.
* coexistence of other neurological diseases